HealthyNCT00812617
Effects of Mineral Water Consumption on Serum Lipid Parameters
A study testing Mineral water (Hita, Oita, Japan) and Mineral water (Aso-gun, Kumamoto, Japan) in people with Healthy, run by Hiroshima University at 1 site in Japan.
Trial summary
The purpose of the study is to determine the effect of a specific mineral water on serum lipid concentrations in healthy subjects. Read more about this study
- Who is it for?
- Ages 20 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy
- What is being tested?
- Mineral water (Hita, Oita, Japan) and Mineral water (Aso-gun, Kumamoto, Japan)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 90 participants
- Where
- 1 siteJapan
- Study dates
- Dec 2008to Sep 2009
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Healthy as based on medical history and physical examination
- Fasting serum LDL cholesterol > 100 and/or fasting serum triglyceride > 100
- Willing to drink mineral water for 12 weeks
- Willing not to serve as blood donor during the study
- Informed consent signed
Who cannot join
- Female subjects who are pregnant or nursing a child
- Participation in any clinical trial up to 90 days before Day 01 of this study
- Renal or hepatic dysfunction
- Heart disease
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Mineral Water Consumption on Serum Lipid Parameters: a Double-Blind, Randomized Controlled Trial
The purpose of the study is to determine the effect of a specific mineral water on serum lipid concentrations in healthy subjects.
- Conditions
- Healthy
- Being tested
- Mineral water (Hita, Oita, Japan), Mineral water (Aso-gun, Kumamoto, Japan)
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mineral water (Hita, Oita, Japan)Dietary supplement
Mineral water (Aso-gun, Kumamoto, Japan)Dietary supplement
| Study group | Role | What they receive |
|---|---|---|
| Mineral water 1 | Experimental | Not described Receives: Dietary Supplement: Mineral water (Hita, Oita, Japan) |
| Mineral water 2 | Experimental | Not described Receives: Dietary Supplement: Mineral water (Aso-gun, Kumamoto, Japan) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Fasting total cholesterol, LDL cholesterol, and triglyceride levels
Measured: Every 4 weeks (Overall 20 weeks)
Secondary outcomes (4)
Fasting serum glucose and HbA1c levels
Measured: Every 4 weeks (Overall 20 weeks)
Serum uric acid level
Measured: Every 4 weeks (Overall 20 weeks)
Serum adiponectin and leptin levels
Measured: Week 0, Week 12
Urinary oxidative stress marker
Measured: Week 0, Week 12
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Dec 2008 (estimated)
- Study startDec 2008
- Study completionSep 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 90 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hiroshima University
- Sponsor type
- University, hospital or other
- Collaborators
- Hita Tenryosui Co., Ltd.
- Investigators
- Fumiko Higashikawa, PhD, Principal investigator, Hiroshima University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00812617
- Sponsor's protocol ID
- eki-77
- Status last verified
- Oct 2009
- First submitted
- 19 Dec 2008
- Last updated
- 6 Oct 2009
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Oct 2009. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Mineral Water Consumption on Serum Lipid Parameters: a Double-Blind, Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT00812617
- Acronym / sponsor ID
- eki-77
- Conditions
- Healthy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 90 participants (estimated)
- Lead sponsor
- Hiroshima UniversityUniversity, hospital or other
- Collaborators
- Hita Tenryosui Co., Ltd.
- Study start
- Dec 2008
- Study completion
- Sep 2009 (actual)
- First posted
- 22 Dec 2008 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the study is to determine the effect of a specific mineral water on serum lipid concentrations in healthy subjects.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Mineral water 1 | Experimental | Dietary Supplement: Mineral water (Hita, Oita, Japan) |
| Mineral water 2 | Experimental | Dietary Supplement: Mineral water (Aso-gun, Kumamoto, Japan) |
Who may qualify
- Ages
- 20 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Healthy as based on medical history and physical examination
- Fasting serum LDL cholesterol > 100 and/or fasting serum triglyceride > 100
- Willing to drink mineral water for 12 weeks
- Willing not to serve as blood donor during the study
- Informed consent signed
Key exclusion criteria (4 listed)
- Female subjects who are pregnant or nursing a child
- Participation in any clinical trial up to 90 days before Day 01 of this study
- Renal or hepatic dysfunction
- Heart disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mineral water (Hita, Oita, Japan) | Dietary supplement | Mineral water 1 |
| Mineral water (Aso-gun, Kumamoto, Japan) | Dietary supplement | Mineral water 2 |
Primary outcome
Fasting total cholesterol, LDL cholesterol, and triglyceride levels
Time frame: Every 4 weeks (Overall 20 weeks)
4 secondary outcomes
Fasting serum glucose and HbA1c levels
Time frame: Every 4 weeks (Overall 20 weeks)
Serum uric acid level
Time frame: Every 4 weeks (Overall 20 weeks)
Serum adiponectin and leptin levels
Time frame: Week 0, Week 12
Urinary oxidative stress marker
Time frame: Week 0, Week 12
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Oct 2009.
Related trials for Healthy
Recruiting
THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS
Physical Activity, Body Image
Not yet recruitingPhase 1
A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants
Atopic Dermatitis
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Not yet recruiting
Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI)
Healthy Volunteers - Male and Female
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Fumiko Higashikawa, PhD principal investigator
Hiroshima University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mineral water (Hita, Oita, Japan) and Mineral water (Aso-gun, Kumamoto, Japan) in people with Healthy, run by Hiroshima University at 1 site in Japan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Oct 2009. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Japan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Fasting total cholesterol, LDL cholesterol, and triglyceride levels (time frame: Every 4 weeks (Overall 20 weeks)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2009.